<SEC-DOCUMENT>0000950170-25-007497.txt : 20250121
<SEC-HEADER>0000950170-25-007497.hdr.sgml : 20250121
<ACCEPTANCE-DATETIME>20250121211029
ACCESSION NUMBER:		0000950170-25-007497
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250121
DATE AS OF CHANGE:		20250121

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aura Biosciences, Inc.
		CENTRAL INDEX KEY:			0001501796
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				320271970
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-40971
		FILM NUMBER:		25543700

	BUSINESS ADDRESS:	
		STREET 1:		80 GUEST STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02135
		BUSINESS PHONE:		(617)500-8864

	MAIL ADDRESS:	
		STREET 1:		80 GUEST STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02135

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			de los Pinos Elisabet
		CENTRAL INDEX KEY:			0001889633
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O AURA BIOSCIENCES, INC.
		STREET 2:		85 BOLTON STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02140
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001889633</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001501796</issuerCik>
<issuerName>Aura Biosciences, Inc. </issuerName>
<secFileNumber>001-40971</secFileNumber>
<issuerAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">80 Guest Street</street1>
<city xmlns="http://www.sec.gov/edgar/common">Boston</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">02135</zipCode>
</issuerAddress>
<issuerContactPhone>617-500-8864</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>de los Pinos Elisabet</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>Officer</relationshipToIssuer>
<relationshipToIssuer>Director</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>Morgan Stanley Smith Barney LLC Drive</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">200 West Civic Center</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">4th Floor</street2>
<city xmlns="http://www.sec.gov/edgar/common">Sandy</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">UT</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">84070</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>15955</noOfUnitsSold>
<aggregateMarketValue>122381.34</aggregateMarketValue>
<noOfUnitsOutstanding>49951466</noOfUnitsOutstanding>
<approxSaleDate>01/21/2025</approxSaleDate>
<securitiesExchangeName>Nasdaq</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<acquiredDate>01/19/2023</acquiredDate>
<natureOfAcquisitionTransaction>Restricted Stock unit award granted pursuant to the Issuer's 2021 Stock Option and Incentive Plan, subject to vesting requirements.</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Aura Biosciences, Inc.</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>30469</amountOfSecuritiesAcquired>
<paymentDate>01/19/2023</paymentDate>
<natureOfPayment>N/A</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<securitiesSoldInPast3Months>
<sellerDetails>
<name>Elisabet de los Pinos</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">80 Guest Street</street1>
<city xmlns="http://www.sec.gov/edgar/common">Boston</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">02135</zipCode>
</address>
</sellerDetails>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<saleDate>10/29/2024</saleDate>
<amountOfSecuritiesSold>9200</amountOfSecuritiesSold>
<grossProceeds>98787.78</grossProceeds>
</securitiesSoldInPast3Months>
<remarks>The sales reported on this Form 144 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.</remarks>
<noticeSignature>
<noticeDate>01/21/2025</noticeDate>
<signature>/s/ Amy Elazzouzi, as Attorney-in-Fact</signature>
</noticeSignature>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
